Feasibility Study for Electroacupuncture for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

Inclusion Criteria: * Must have undergone chemotherapy with taxane and/or platinum agent * Presence of numbness, paresthesias, loss of deep tendon reflexes, or other symptoms in the lower extremities those were absent prior to treatment with neurotoxic chemotherapy. * Three or more months status post platinum containing chemotherapy completion * Grade ≥1 Level of CIPN that is determined by the NCI Common Toxicity Criteria for Adverse Events. Exclusion Criteria: * Peripheral neuropathy from causes other than chemotherapy, such as documented * a. Nerve compression (carpal tunnel syndrome, sciatica, etc) * b. Previously known leptomeningeal carcinomatosis * c. Evidence of disease in the brain or spine by prior imaging * Comorbidities with documented pre-existing neuropathy prior to the chemotherapy such as * a. Diabetes (HbA1c 6.5% or greater) * b. HIV * c. Multiple myeloma * d. Alcoholism * Pain medication dosing, including opioids, anti-convulsants, and anti- depressantshas been increased due to worsening symptoms less than in the two weeks prior to study registration * Current use of acupuncture (manual or electro acupuncture) * Pregnancy * Cardiac issues (AHA class 3 or greater) * Pacemaker or an imbedded neural stimulator * Full therapeutic anticoagulation or a INR \> 1.4 * Currently undergoing chemotherapy with a platinum agent or have received a platinum chemotherapy agent in the past 3 months.